CD Targeted Cell Therapy Market
完整報告名稱與涵蓋範圍
CD Targeted Cell Therapy Market Size, Share & Trends Analysis Report By Indication Type (Diffuse Large B-Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Acute Lymphoblastic Leukemia, and Others), By Target Type, Region And Segment Forecasts, 2023-2031.
報告摘要
The global CD Targeted Cell Therapy Market is set to witness substantial expansion over the coming years.
At its core, CD Targeted Cell Therapy pertains to a comprehensive analysis, forecast, market dynamics, and major trends report, covering critical market data on th. Stakeholders across the healthcare landscape are escalatingly turning to these solutions to meet contemporary demands.
Market momentum is driven by escalating appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1.Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2.Executive Summary
Chapter 3.Global CD Targeted Cell Therapy Market Snapshot
Chapter 4.Global CD Targeted Cell Therapy Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5.Market Segmentation 1: By Indication Type Estimates & Trend Analysis
5.1. By Indication Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Indication Type:
5.2.1. Diffuse large B-cell lymphoma
5.2.2. Chronic lymphocytic leukemia
5.2.3. Multiple myeloma
5.2.4. Acute lymphoblastic leukemia
5.2.5. Others
Chapter 6.Market Segmentation 2: By Target Type Estimates & Trend Analysis
6.1. By Target Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Target Type:
6.2.1. CD19
6.2.2. CD20
6.2.3. CD33
Chapter 7.CD Targeted Cell Therapy Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Indication Type, 2023-2031
7.1.2. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.1.3. North America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.2.2. Europe CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.2.3. Europe CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.3.2. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.3.3. Asia Pacific CD Targeted Cell Therapy Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, 2023-2031
7.4.2. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.4.3. Latin America CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by By Indication Type, (US$ Million)
7.5.2. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) estimates and forecasts By Target Type, 2023-2031
7.5.3. Middle East & Africa CD Targeted Cell Therapy Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8.Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Juno Therapeutics
8.2.2. Agios Pharmaceutical
8.2.3. Aurora BioPharma
8.2.4. Atara Biotherapeutics
8.2.5. AryoGen Biopharma
8.2.6. Shenzhen BinDeBio Ltd.
8.2.7. China Immunotech Co., Ltd.
8.2.8. Autolus Limited
8.2.9. Kite Pharma
8.2.10. Bellicum Pharmaceuticals
8.2.11. bluebird bio
8.2.12. Calibr
8.2.13. Carina Biotech
8.2.14. CARsgen Therapeutics
8.2.15. Celgene Corporation
8.2.16. Cellectis
8.2.17. Cell Medica
8.2.18. AbbVie
8.2.19. Allogene Therapeutics
8.2.20. Amgen
8.2.21. Cell Design Labs
8.2.22. Celularity
8.2.23. Celyad
8.2.24. Fate Therapeutics
8.2.25. Fortress Bio
8.2.26. Gilead Sciences
8.2.27. Sorrento Therapeutics, Inc.
8.2.28. Ziopharm
8.2.29. Janssen Biotech
8.2.30. JW Therapeutics
8.2.31. Medisix Therapeutics
8.2.32. Mustang Bio
8.2.33. Nanjing Legend Biotech
8.2.34. Precision Biosciences
8.2.35. Posedia Therapeutics
8.2.36. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們